SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001062993-22-022516
Filing Date
2022-11-21
Accepted
2022-11-21 08:28:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A formsc13da.htm SC 13D/A 24292
  Complete submission text file 0001062993-22-022516.txt   25713
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Subject) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90477 | Film No.: 221403547
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 PLACE VENDOME PARIS I0 75001
Business Address 19 PLACE VENDOME PARIS I0 75001 158625500
DNCA FINANCE (Filed by) CIK: 0001752759 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A